The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters. Guven DC, Sahin TK, Aksoy S. Breast J 2020 Aug 19. doi: 10.1111/tbj.14027.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guven DC, Sahin TK, Aksoy S. The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters. Breast J 2020 Aug 19. doi: 10.1111/tbj.14027.
PMID: 32812288